Lexeo Therapeutics Stock Quote LXEO - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

12.55

Bid

11.50

Ask

13.10

Volume

196,751

12.27 Day's Range 12.86

9.00 52 Week Range 22.33

Market Cap

413.464M

Previous Close

12.72

Open

12.86

Last Trade

12.6

Last Trade Time

17:59:30

Financial Volume

$ 2,472,079

VWAP

12.5645

Average Volume (3m)

299,679

Shares Outstanding

32,945,341

Dividend Yield

PE Ratio

-6.24

Earnings Per Share (EPS)

-2.02

Revenue

Net Profit

-66.39M

Lexeo Therapeutics, Inc. operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich's ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene t... Lexeo Therapeutics, Inc. operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich's ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene therapy candidate for the treatment of arrhythmogenic cardiomyopathy; LX2021, a gene therapy candidate for the treatment of DSP cardiomyopathy associated; and LX2022, a gene therapy candidate for the treatment of HCM caused by TNNI3 mutations. It also develops LX1001, an AAVrh10-based gene therapy candidate for the treatment of APOE4 homozygous; LX1020, a gene therapy candidate for the treatment of APOE4 homozygous; LX1021 for the treatment of APOE4 homozygotes; and LX1004 for the treatment of CLN2 Batten disease. The company was incorporated in 2017 and is based in New York, New York. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.lexeotx.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Lexeo Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker LXEO. The last closing price for Lexeo Therapeutics was $12.72. Over the last year, Lexeo Therapeutics shares have traded in a share price range of $ 9.00 to $ 22.33.

Lexeo Therapeutics currently has 32,945,341 shares outstanding. The market capitalization of Lexeo Therapeutics is $419.06 million. Lexeo Therapeutics has a price to earnings ratio (PE ratio) of -6.24.

Iovance Biotherapeutics to Host Second Quarter and First Half 2024 Financial Results Conference Call and Webcast on Thursday, August 8, 2024

SAN CARLOS, Calif., July 29, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal...

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SAN CARLOS, Calif., July 19, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) (“Iovance” or the “Company”), a biotechnology company focused on innovating, developing, and...

Form 4 - Statement of changes in beneficial ownership of securities

Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma

First of Multiple Planned Global Submissions for Lifileucel in 2024 and 2025 Key Step in Global Expansion to Address >20,000 Patients Annually with Previously Treated Advanced Melanoma SAN...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.76	6.44614079729	11.79	12.99	11.36	419470	12.18358211	CS
4	-1.23	-8.9259796807	13.78	19.5	10.9	516302	13.70401108	CS
12	-0.75	-5.63909774436	13.3	19.5	10.9	299679	14.71413693	CS
26	-4.33	-25.6516587678	16.88	19.5	10.9	198536	14.62685888	CS
52	3.05	32.1052631579	9.5	22.33	9	176774	14.24943259	CS
156	3.05	32.1052631579	9.5	22.33	9	176774	14.24943259	CS
260	3.05	32.1052631579	9.5	22.33	9	176774	14.24943259	CS

Symbol	Price	Vol.
IMRXImmuneering Corporation	$ 1.63 (44.25%)	6.54M
CDNACareDx Inc	$ 26.00 (30.07%)	90.45k
MDJHMDJM Ltd	$ 2.06 (27.95%)	1.46M
KXINKaixin Holdings	$ 0.1319 (18.30%)	5.13M
EOLSEvolus Inc	$ 14.35 (15.54%)	19.33k
ALXOALX Oncology Holdings Inc	$ 3.32 (-30.83%)	3.75M
NCNCnoco noco Inc	$ 0.221 (-23.00%)	3.85M
ATECAlphatec Holdings Inc	$ 8.08 (-20.00%)	340.83k
UDMYUdemy Inc	$ 7.50 (-18.83%)	122.55k
LABStandard BioTools Inc	$ 1.89 (-15.63%)	44.22k
NVDANVIDIA Corporation	$ 121.51 (3.84%)	24.44M
METAMeta Platforms Inc	$ 509.72 (7.35%)	7.1M
SQQQProShares UltraPro Short QQQ	$ 8.36 (-2.68%)	6.74M
IMRXImmuneering Corporation	$ 1.63 (44.25%)	6.54M
CTNTCheetah Net Supply Chain Service Inc	$ 0.2997 (9.50%)	6.07M

Symbol

Price

Vol.